Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two Decades
Simay Çokgezer,1 Tuğrul Elverdi,2 Ayşe Salihoğlu,2 Muhlis Cem Ar,2 Şeniz Öngören,2 Zafer Başlar,2 Ahmet Emre Eşkazan2 1Department of Internal Medicine, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medici...
Main Authors: | Çokgezer S, Elverdi T, Salihoğlu A, Ar MC, Öngören, Başlar Z, Eşkazan AE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-06-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/treatment-responses-toxicity-and-survival-in-patients-with-classical-h-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report
by: Ken Tanaka, et al.
Published: (2023-11-01) -
Management of classical Hodgkin lymphoma: a look at up to date evidence and current treatment approaches
by: Walter Hanel, et al.
Published: (2022-12-01) -
Current directions in the treatment of classical Hodgkin lymphoma
by: Frank G. Keller, et al.
Published: (2023-11-01) -
Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL
by: Mahdi Nohtani, et al.
Published: (2022-09-01) -
Advances in the treatment of Hodgkin lymphoma: Current and future approaches
by: Fauzia Ullah, et al.
Published: (2023-03-01)